Hunan Fangsheng Pharmaceutical Co., Ltd. (603998.SS)

CNY 10.84

(0.18%)

Market Cap (In CNY)

4.7 Billion

Revenue (In CNY)

1.62 Billion

Net Income (In CNY)

186.82 Million

Avg. Volume

4.72 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
7.12-13.58
PE
-
EPS
-
Beta Value
0.341
ISIN
CNE100001VG6
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Ms. Xiaoli Zhou
Employee Count
-
Website
https://www.fangsheng.com.cn
Ipo Date
2014-12-05
Details
Hunan Fangsheng Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in China. It offers medicines in the form of tablets, capsules, and granules for cardiovascular and cerebrovascular, orthopedic, pediatric, gynecological, traumatology, and anti-infectives. The company was founded in 2002 and is based in Changsha, China.